Published in PLoS One on May 17, 2013
Optimizing Drug-Therapy in Patients 80 Years and Older | NCT00661310
Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial. PLoS One (2015) 1.16
The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging (2013) 1.10
Collaborative pharmaceutical care in an Irish hospital: uncontrolled before-after study. BMJ Qual Saf (2014) 1.06
The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.84
Potentially inappropriate prescribing in older primary care patients. PLoS One (2014) 0.81
A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data. BMJ Open (2015) 0.80
Medication misadventures in older adults: literature from 2013. J Am Geriatr Soc (2014) 0.79
The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS One (2014) 0.78
Doctors' and nurses' perceptions of a ward-based pharmacist in rural northern Sweden. Int J Clin Pharm (2017) 0.77
[Not Available]. Can J Hosp Pharm (2016) 0.75
Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol (2016) 0.75
Protecting Our Elderly Patients from Adverse Drug Reactions. Can J Hosp Pharm (2016) 0.75
A comparison of estimated drug costs of potentially inappropriate medications between older patients receiving nurse home visit services and patients receiving pharmacist home visit services: a cross-sectional and propensity score analysis. BMC Health Serv Res (2015) 0.75
Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP/START criteria: a cross-sectional study. Clin Interv Aging (2016) 0.75
Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients. Am Health Drug Benefits (2016) 0.75
Quality of pharmacotherapy in old age: focus on lists of Potentially Inappropriate Medications (PIMs) : Consensus statements from the European Science Foundation exploratory workshop. Eur J Clin Pharmacol (2016) 0.75
Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry. Int J Clin Pharm (2017) 0.75
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc (2012) 13.94
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med (2003) 13.47
Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA (1999) 10.77
Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med (1997) 5.90
Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med (2006) 5.58
Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med (1991) 5.30
Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet (2007) 5.20
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther (2008) 5.17
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med (2011) 3.88
A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med (2009) 3.83
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med (1996) 3.53
STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing (2008) 3.42
Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev (2012) 2.67
Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc (2001) 2.61
Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med (2005) 2.55
Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther (2011) 2.22
A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol (1994) 2.05
START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing (2007) 1.80
Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc (2007) 1.69
Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother (2004) 1.68
From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care (2001) 1.55
Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med (2002) 1.54
Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc (1990) 1.41
Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care (2003) 1.39
Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing (2007) 1.32
Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol (2011) 1.30
How can clinicians measure safety and quality in acute care? Lancet (2004) 1.25
Prevalence and outcomes of use of potentially inappropriate medicines in older people: cohort study stratified by residence in nursing home or in the community. BMJ Qual Saf (2011) 1.20
Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging (2010) 1.11
The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging (2012) 1.11
Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging (2012) 1.10
Conflicts and concordance between measures of medication prescribing quality. Med Care (2007) 1.10
Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing (2009) 1.08
Medication-related problems in the elderly : defining the issues and identifying solutions. Drugs Aging (2005) 1.07
An innovative approach to integrated medicines management. J Eval Clin Pract (2007) 1.05
A review of some statistical methods for covariance analysis of categorical data. Biometrics (1982) 1.03
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf (2010) 1.00
Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc (2012) 0.99
Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. Am J Health Syst Pharm (2009) 0.92
Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people. J Eval Clin Pract (2011) 0.87
A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med (2009) 3.83
Serum retinol levels and the risk of fracture. N Engl J Med (2003) 3.29
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation (2009) 2.85
Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ (2009) 2.79
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis (2009) 2.70
Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ (2013) 2.17
Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis (2009) 1.97
Genetic liability to fractures in the elderly. Arch Intern Med (2005) 1.88
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther (2009) 1.87
Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol (2007) 1.66
Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol (2008) 1.65
Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr (2010) 1.64
Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum (2009) 1.62
Morphine metabolism after major liver surgery. Anesth Analg (2007) 1.54
Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ (2011) 1.53
A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics (2003) 1.52
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos (2008) 1.50
Determining vitamin D status: a comparison between commercially available assays. PLoS One (2010) 1.49
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther (2010) 1.49
Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med (2009) 1.48
Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment. J Hypertens (2004) 1.45
Leisure physical activity and the risk of fracture in men. PLoS Med (2007) 1.41
[Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy]. Lakartidningen (2003) 1.39
Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res (2004) 1.36
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res (2007) 1.35
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One (2009) 1.25
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET. Neuroimage (2006) 1.17
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods. Drug Metab Dispos (2010) 1.16
Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm Res (2003) 1.11
Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol. Free Radic Biol Med (2009) 1.11
In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids. Drug Metab Dispos (2007) 1.09
Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone (2003) 1.07
Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail (2010) 1.05
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem (2009) 1.01
Development of a high-throughput brain slice method for studying drug distribution in the central nervous system. Drug Metab Dispos (2009) 1.01
AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol (2007) 1.01
Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study. Nutr Metab (Lond) (2010) 0.99
Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab (2008) 0.99
In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics. Drug Metab Dispos (2006) 0.99
Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis (2012) 0.98
Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab Dispos (2008) 0.98
Improved measurement of drug exposure in the brain using drug-specific correction for residual blood. J Cereb Blood Flow Metab (2009) 0.98
Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study. BMC Cancer (2008) 0.97
Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans. J Pharmacokinet Pharmacodyn (2012) 0.96
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. J Hypertens (2002) 0.95
Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu). Drug Metab Dispos (2005) 0.95
Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology (2008) 0.94
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier. Pharm Res (2006) 0.94
Blood-brain barrier transport of morphine in patients with severe brain trauma. Br J Clin Pharmacol (2004) 0.92
Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin. Antimicrob Agents Chemother (2003) 0.92
Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med (2008) 0.92
Perceived value of ward-based pharmacists from the perspective of physicians and nurses. Int J Clin Pharm (2012) 0.92
Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833. J Pharm Sci (2005) 0.91
Intake and serum concentrations of α-tocopherol in relation to fractures in elderly women and men: 2 cohort studies. Am J Clin Nutr (2013) 0.91
Direct nose-to-brain transfer of morphine after nasal administration to rats. Pharm Res (2006) 0.90
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens (2002) 0.90
Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK. PLoS One (2010) 0.89
Vitamin a is a negative regulator of osteoblast mineralization. PLoS One (2013) 0.89
Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment. Ups J Med Sci (2004) 0.89
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Am J Hypertens (2004) 0.88
A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. Biochem Biophys Res Commun (2002) 0.88
Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population. Eur J Pharm Sci (2003) 0.87
Relations of circulating vitamin D concentrations with left ventricular geometry and function. Eur J Heart Fail (2012) 0.87
Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev (2010) 0.87
Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report. BMC Psychiatry (2004) 0.86
Prescription and transcription errors in multidose-dispensed medications on discharge from hospital: an observational and interventional study. J Eval Clin Pract (2011) 0.86
Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo. J Pharm Sci (2011) 0.86
The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol (2014) 0.86
Risk of severe knee and hip osteoarthritis in relation to level of physical exercise: a prospective cohort study of long-distance skiers in Sweden. PLoS One (2011) 0.85
Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs. Curr Top Med Chem (2010) 0.85
Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension. Eur J Clin Invest (2011) 0.85
Population density and mortality among individuals in motor vehicle crashes. Inj Prev (2010) 0.85
Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab (2002) 0.85
High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats. Bone (2010) 0.84
The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies. J Pharm Sci (2008) 0.84
Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins. J Bone Miner Res (2014) 0.84
Association between repeat length of exon 1 CAG microsatellite in the androgen receptor and bone density in men is modulated by sex hormone levels. Calcif Tissue Int (2008) 0.83
Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. J Psychiatr Res (2007) 0.83
Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 0.83
Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study. Mol Pharm (2012) 0.83
Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study. Circ Heart Fail (2013) 0.83
The brain slice method for studying drug distribution in the CNS. Fluids Barriers CNS (2013) 0.82
Prehospital Trauma Life Support (PHTLS) training of ambulance caregivers and impact on survival of trauma victims. Resuscitation (2012) 0.82
Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. BMC Med (2004) 0.82
Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly women. J Clin Endocrinol Metab (2013) 0.82
Influence of probenecid on the delivery of morphine-6-glucuronide to the brain. Eur J Pharm Sci (2005) 0.81
Prediction of fracture risk in men: a cohort study. J Bone Miner Res (2012) 0.81